Status:
RECRUITING
OBSERVATIONAL STUDY ON VIRAL SHEDDING AND IMMUNOLOGICAL RESPONSE OF OROPOUCHE VIRUS
Lead Sponsor:
IRCCS Sacro Cuore Don Calabria di Negrar
Conditions:
Oropouche Infection
Eligibility:
All Genders
18+ years
Brief Summary
This is a single-center observational study, whose primary objective is to describe the immune response to Oropouche Virus (OROV) during the study period and the duration of viral RNA shedding, only f...
Detailed Description
This is a study with retrospective and prospective enrollment.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- patients resulted positive to the RT-PCR for OROV;
- informed consent to the participation to the study and to personal data's treatment and/or donation of residual samples to Tropika Biobank;
- patients ≥ 18 years old.
- Exclusion Criteria
- • lack of signed informed consent.
Exclusion
Key Trial Info
Start Date :
December 19 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06892015
Start Date
December 19 2024
End Date
October 1 2026
Last Update
May 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Sacro Cuore Don Calabria
Negrar, VR, Italy, 37024